1 / 29

CLUSTER IMMUNOTHERAPY

CLUSTER IMMUNOTHERAPY. Overview. Main difference: time required to reach maintenance dose. Definition. Cluster immunotherapy Accelerated build-up schedule

decker
Download Presentation

CLUSTER IMMUNOTHERAPY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CLUSTER IMMUNOTHERAPY

  2. Overview Main difference: time required to reach maintenance dose.

  3. Definition • Cluster immunotherapy • Accelerated build-up schedule • Entails administering several injections at increasing doses (generally 2-3 per visit) sequentially in a single day of treatment on nonconsecutive days • The maintenance dose is generally achieved more rapidly than with a conventional (single injection per visit) build-up schedule (generally within 4 to 8 weeks)

  4. Definition Total injections to maintenance: 18 Total injections to maintenance: 30

  5. April, 1930 “Leisurely desensitisation” • Inoculations given weekly merely because our outpatients were in the habit of coming every week. • In view of subsequent quicker methods I have called this older method “leisurely.”

  6. April, 1930 “Intensive desensitisation” • Later, I fell into the way of inoculating these patients every day with gradually increasing doses (a 10 to 20 percent increase). • This intensive method proved so successful, and was in some ways so convenient, that I have used it increasingly ever since. “Rush desensitisation” • The injections are given every hour and a half to two hours throughout a 14 hour day. Thus a very satisfactory course can be put through in from two to four days. • The patient must go into hospital, or at any rate be in the charge of a trained nurse, under the constant supervision of a doctor.

  7. Why accelerate IT? • Clinical benefit of IT obtained sooner (reach maintenance vial promptly before allergy season) • Increased adherence to schedule? The most common reasons for noncompliance with IT included inconvenience, precluding medical conditions, and adverse systemic reactions (More, Annals 08) • Patients that turn down conventional IT might choose cluster if given the option. Only 5% of patients with allergic asthma and/or AR receive IT.

  8. Why accelerate IT? • Fewer total injections also result in: • Less opportunity for administration errors • Less expensive build-up phase of IT (less allergen and associated supplies needed, fewer insurance copays)

  9. Why not accelerate IT? • AIPP: “…slightly increased frequency of systemic reactions” • >1 injection per visit, >1 opportunities to have a reaction at that visit

  10. Cluster vs. Conventional IT • Very few studies compare cluster with conventional IT head-to-head • Few studies use the same: • Cluster (or conventional) injection schedule • Allergens • Patient population • Target maintenance dose • Definition of systemic reaction • Some studies premedicate! • Measures of clinical efficacy • Length of study

  11. Comparison studies Systemic reactions not broken down by phase of IT

  12. Comparison studies Systemic reactions during build-up phase: 0.8% of cluster inj vs. 0.74% of convinj

  13. Comparison studies • Did not assess clinical efficacy • Maintenance dose of Derp 1 was 5000 TU(?) • Small study excluding severe asthma • Community Based Experience with Cluster IT (Harvey, JACI abstract 2/2006) • Peds/adult with asthma/AR, (?allergen), 9 wk cluster (n=48) vs. 22 wk conventional (24) • Systemic rxn mild (tx with antihistamines); 0.3% of cluster inj vs. 0.2% conventional inj

  14. Prospective studies • Basic design of prospective cluster IT studies: enroll patients, put them on cluster protocol, report outcome. • Can compare cluster studies’ reaction rates with published conventional IT studies:

  15. Prospective studies • Clinical efficacy not reported • Maintenance doses a little questionable

  16. Prospective studies • Did not assess clinical efficacy • Maintenance dose unclear to me, unstandardized extracts

  17. Purrrspsective studies • Probable effective dose for cat immunotherapy: 11-17 μgFeld 1

  18. Yet more Clustered schedules in allergen SIT (Parmiani, Allergol et Imm 02) • Reviewed 21 studies involving aeroallergens from 80’s-90’s (rest were VIT) • Systemic rxn rates all <1% of inj in studies looking at cluster schedule

  19. Premedication Lawsuit shock Premedication masking systemic reaction sx Systemic reaction +Angioedema Urticaria Mild or Subclinical 1:1000 1:100 1:10 maintenance Allergen dose over time

  20. Premedication

  21. Premedication Systemic reactions not broken down by allergen used for immunotherapy

  22. Premedication • Does premedication alter the efficacy of IT? Rush IT (4 inj/day x 4 days) Sting or field challenge (3 years later) 26 Pretreat with terfenadine 20 0 Systemic reactions 52 Bee allergic patients 26 Pretreat with placebo 6 Systemic reactions 21 Premedication with antihistamines may enhance efficacy of specific-allergen IT (Muller, JACI 2001)

  23. Cluster candidates • ACAAI instant reference: • “while there are no firm indications for accelerated schedules, the following patients and/or situations may benefit from such schedules” • Poor adherence or systemic rxns with conventional IT • Work/life schedule precludes weekly injections for a prolonged time • Asthmatics that can only be controlled long enough to reach a maintenance dose with an accelerated schedule • David Khan, MD – Patient selection for rush and cluster IT (presented at AAAAI 2010) • “Summary: Any patient who is considered a candidate for IT is a candidate for cluster or RIT.”

  24. Cluster candidates • Maintenance dose or identity/number of grass allergens not reported • Cluster schedule very aggressive compared to AIPP

  25. Immunogenicity Safety and Immunogenicity of Cluster IT in Children with Asthma and Mite Allergy (Schubert, Int Arch All Imm 2009)

  26. Skin test reactivity Cutaneous Tolerance Index (CTI) = number of times in which it is necessary to multiply the concentrations of an extract, in order to obtain the same wheal areas as those obtained by the same concentrations of another extract DB comparative study of cluster and conventional IT schedules with D. pteronyssinus(Tabar, JACI 05)

  27. Final thoughts • Cluster immunotherapy is as safe and cheaper/faster than conventional IT. • Premedication further diminishes the risk of a serious systemic reaction. • AIPP example cluster schedule is more conservative than many of the studies reviewed today, and in some cases our maintenance dose would be lower. • Let’s do premedicated cluster IT here! Get your shots and gooooooo!

More Related